Nirsevimab: A Review

• 2024

  Log in to bookmark this resource.

  Log in
• Howard Balbi
PMID: 38484270DOI: https://dx.doi.org/10.1089/ped.2024.0025

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This review article focuses on nirsevimab, a new monoclonal antibody approved by the FDA in July 2023 to prevent RSV disease in infants and young children. It describes how RSV is a major cause of lung infections, especially in infants. In 2023, the FDA also approved two vaccines for older adults and one for pregnant women to protect newborns. Nirsevimab is recommended by health experts for all infants under 8 months old and certain high-risk children up to 19 months old. The article highlights its importance as part of recent advancements in RSV prevention strategies.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Infant; Infant, Newborn; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Respiratory Syncytial Virus, Human; Antibodies, Monoclonal, Humanized

Institutions: Good Samaritan University Hospital

---

More like this

Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt 2023 · Hôpital Antoine-Béclère AP-HP, Université Paris-Saclay, American College of Emergency Physicians, Hospital General Universitario Gregorio Marañón, St. Marien Children's Hospital, University Medical Centre Utrecht, Respiratory Syncytial Virus NETwork (ReSViNET) Foundation, University Hospital of Padova Are Tertiary Care Paediatricians Prepared for Disaster Situations? 2016 · ZNA Stuivenberg, Ghent University Hospital, University of Leuven Pre-Pandemic Planning Survey of Healthcare Workers at a Tertiary Care Children's Hospital: Ethical and Workforce Issues 2010 · University of Colorado, Keesler Medical Center

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---